O-1871 (original) (raw)

About DBpedia

O-1871 is a potent cannabinoid agonist which was invented by Billy R Martin and Raj K Razdan at Organix Inc in 2002. It has a CB1 receptor affinity of 2.0nM and a CB2 receptor affinity of 0.3nM. Structurally, O-1871 is a cyclohexylphenol derivative related to CP 47,497, and so is illegal in some jurisdictions where CP 47,497 and its derivatives are banned. However the 3,3-dimethylcyclohexyl substituent of O-1871 can be replaced by various other groups, producing other potent compounds such as the cycloheptyl derivative O-1656 and the 2-adamantyl derivative O-1660, as well as the corresponding 3,5-dichlorophenyl derivative, which are not cyclohexylphenol derivatives.

thumbnail

Property Value
dbo:abstract O-1871 is a potent cannabinoid agonist which was invented by Billy R Martin and Raj K Razdan at Organix Inc in 2002. It has a CB1 receptor affinity of 2.0nM and a CB2 receptor affinity of 0.3nM. Structurally, O-1871 is a cyclohexylphenol derivative related to CP 47,497, and so is illegal in some jurisdictions where CP 47,497 and its derivatives are banned. However the 3,3-dimethylcyclohexyl substituent of O-1871 can be replaced by various other groups, producing other potent compounds such as the cycloheptyl derivative O-1656 and the 2-adamantyl derivative O-1660, as well as the corresponding 3,5-dichlorophenyl derivative, which are not cyclohexylphenol derivatives. (en)
dbo:casNumber 620964-96-7
dbo:fdaUniiCode SGY2L36FDU
dbo:pubchem 10405368
dbo:thumbnail wiki-commons:Special:FilePath/O-1871_structure.png?width=300
dbo:wikiPageExternalLink https://pubchem.ncbi.nlm.nih.gov/compound/21087754 https://pubchem.ncbi.nlm.nih.gov/compound/58803980
dbo:wikiPageID 39943711 (xsd:integer)
dbo:wikiPageLength 3035 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID 1108882085 (xsd:integer)
dbo:wikiPageWikiLink dbr:Cannabicyclohexanol dbr:Cannabidiol dbr:O-1656 dbc:Cannabinoids dbr:CP_47,497 dbr:CP_55,940 dbc:2,6-Dihydroxybiphenyls dbr:Organix_Inc dbr:Cannabinoid dbr:Cannabinor dbr:Cannabinoid_receptor_1 dbr:Cannabinoid_receptor_2 dbr:File:O-1656_structure.png dbr:File:O-1660_structure.png
dbp:atcPrefix none (en)
dbp:c 23 (xsd:integer)
dbp:casNumber 620964 (xsd:integer)
dbp:chemspiderid 8580806 (xsd:integer)
dbp:h 38 (xsd:integer)
dbp:iupacName 2 (xsd:integer)
dbp:legalStatus Banned as cyclohexylphenol derivative (en)
dbp:o 2 (xsd:integer)
dbp:pubchem 10405368 (xsd:integer)
dbp:smiles CCCCCC1C2=CC=CC=C2O (en)
dbp:stdinchi 1 (xsd:integer)
dbp:stdinchikey WBSPBIRKSHKQQD-UHFFFAOYSA-N (en)
dbp:unii SGY2L36FDU (en)
dbp:width 280 (xsd:integer)
dbp:wikiPageUsesTemplate dbt:Cannabinoid-stub dbt:Cannabinoids dbt:Clear-left dbt:Drugbox dbt:Reflist dbt:Short_description dbt:Cascite dbt:Fdacite
dcterms:subject dbc:Cannabinoids dbc:2,6-Dihydroxybiphenyls
gold:hypernym dbr:Agonist
rdf:type owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:Drug
rdfs:comment O-1871 is a potent cannabinoid agonist which was invented by Billy R Martin and Raj K Razdan at Organix Inc in 2002. It has a CB1 receptor affinity of 2.0nM and a CB2 receptor affinity of 0.3nM. Structurally, O-1871 is a cyclohexylphenol derivative related to CP 47,497, and so is illegal in some jurisdictions where CP 47,497 and its derivatives are banned. However the 3,3-dimethylcyclohexyl substituent of O-1871 can be replaced by various other groups, producing other potent compounds such as the cycloheptyl derivative O-1656 and the 2-adamantyl derivative O-1660, as well as the corresponding 3,5-dichlorophenyl derivative, which are not cyclohexylphenol derivatives. (en)
rdfs:label O-1871 (en)
owl:sameAs freebase:O-1871 wikidata:O-1871 dbpedia-sh:O-1871 dbpedia-sr:O-1871 https://global.dbpedia.org/id/Xorc
prov:wasDerivedFrom wikipedia-en:O-1871?oldid=1108882085&ns=0
foaf:depiction wiki-commons:Special:FilePath/O-1656_structure.png wiki-commons:Special:FilePath/O-1660_structure.png wiki-commons:Special:FilePath/O-1871_structure.png
foaf:isPrimaryTopicOf wikipedia-en:O-1871
is dbo:wikiPageWikiLink of dbr:Cannabicyclohexanol dbr:List_of_psychedelic_drugs dbr:O-1656 dbr:CBD-DMH dbr:CP_47,497 dbr:Tetrahydrocannabiphorol dbr:C23H38O2 dbr:Organix_Inc dbr:Cannabinor dbr:Structural_scheduling_of_synthetic_cannabinoids
is foaf:primaryTopic of wikipedia-en:O-1871